DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Dermatan sulfate
Dermatan sulfate
Surfen, a Small Molecule Antagonist of Heparan Sulfate
Dermatan Sulfate Composition
Search Strategy, Baseline Risk Coronavirus and Prophylaxis For
Products for Heparin Analysis
Dermatan Sulfate Is the Predominant Antithrombotic Glycosaminoglycan in Vessel Walls: Implications for a Possible Physiological Function of Heparin Cofactor II
Modulation of Heparin Cofactor II Activity by Histidine-Rich Glycoprotein and Platelet Factor 4
Extended Physicochemical Characterization of the Synthetic Anticoagulant Pentasaccharide Fondaparinux Sodium by Quantitative NMR and Single Crystal X-Ray Analysis
The Anticoagulant and Nonanticoagulant Properties of Heparin
Effective Inhibition of SARS-Cov-2 Entry by Heparin and Enoxaparin Derivatives
Effectiveness and Safety of Sulodexide in the Treatment of Venous Diseases
Structural Characterization of a Clinically Described Heparin-Like Substance in Plasma Causing Bleeding T
Heparin, Heparan Sulfate, and Dermatan Sulfate Regulate Formation of the Insulin-Like Growth Factor-I and Insulin-Like Growth Factor-Binding Protein Complexes*
Biocatalysis and Pharmaceuticals a Smart Tool for Sustainable Development
Discovery of an Intrinsic Tenase Complex Inhibitor: Pure Nonasaccharide from Fucosylated Glycosaminoglycan
Identification Pharmacology
DERMATAN SULFATE: a NEW CONCEPT in ANTITHROMBOTIC THERAPY DOCTOR of PHILOSOPHY (1991) Mcmaster UNIVERSITY Hamilton, Ontario
A Fluorescent Probe for Glycosaminoglycans Applied to the Detection of Dermatan Sulfate by a Mix-And-Read Assay
1 March 24, 2021 the Degree of Polymerization and Sulfation
Top View
Determination of Oversulfated Chondroitin Sulfate and Dermatan Sulfate in Heparin Sodium Using Anion-Exchange Chromatography with UV Detection
Marine Antithrombotics
Australian Statistics on Medicines 2009
Associated Thrombosis Covid-19
Direct Thrombin Inhibitors
Redalyc.Inhibition of Thrombin Generation by Dermatan Sulfate
Changes in the Composition and Structure of Glycosaminoglycans in the Human Placenta During Development
Characterization of Danaparoid Complex Extractive Drug by an Orthogonal Analytical Approach
Glycosaminoglycans
United States Patent (19) 11 Patent Number: 5,801,162 Takada Et Al
Inhixa, INN Enoxaparin Sodium
BLOOD RESEARCH June 2016 ARTICLE
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Klasifikacija ATC 2021
A Cerebrospinal Fluid Collection Study in Pediatric and Adult Patients with Hunter Syndrome
090497 Low-Molecular-Weight Heparins
Glycosaminoglycans for the Treatment for Pre-Eclampsia and Related Diseases
Heparins and Substances of Natural Origin in the European Pharmacopoeia
Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy
Interaction of Small Dermatan Sulfate Proteoglycan from Fibroblasts With
ATC Code Title
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Genes Differentially Expressed at 1 Day, 6 Weeks, and 6 Months of Age in Aortas of Spontaneously Atherosclerotic White Carneau Pigeons